Non-Small Cell Adenocarcinoma — Trials

Non-Small Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

236 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 53
Recruiting: 28
Ph III recruiting: 6
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (29)

clinicaltrialsPublishedShowing 1–43 of 43 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07705035	DBC-664 in Adult Patients With Solid Tumors	recruiting	Phase 1	210	Duboce Biopharmaceuticals, Inc.INDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT04105270	RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial	recruiting	Phase 2	82	Masonic Cancer Center, University of MinnesotaOTHER	1	Sep 17, 2026	clinicaltrials